Understanding the signaling cascades leading to the NK cellular response, and specifically the influence of ARF on SHP-1 activity, may lead to innovative approaches influencing NK cell functions in cancer, viral-infections, and autoimmune diseases. The gene discussed is CDKN2A; the disease is cancer.